Hela-DFO treated (0.5mM, 24h) Nuclear Lysate
Be the first to review this product! Submit a review
|
(1 Publication)
- WB
Unknown
Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (AB180880)
Abcam recommends using 5% milk as the blocking agent, decreasing to 2% milk during primary and secondary incubation. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (<a href='/en-us/products/primary-antibodies/hif-1-alpha-antibody-ep1215y-ab51608'>ab51608</a>) at 1/2000 dilution
Lane 1:
Western blot - HeLa nuclear extract lysate (<a href='/en-us/products/cell-lysates/hela-nuclear-extract-lysate-ab150036'>ab150036</a>) at 40 µg
Lane 2:
Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880) at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution
Predicted band size: 92 kDa
Observed band size: 110 kDa
true
Exposure time: 8min
- WB
Lab
Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (AB180880)
We recommend using 5% milk in TBST as the blocking agent, decreasing to 2% milk in TBST during primary and secondary antibody incubation.
Blots were developed with Goat Anti-Mouse IgG H&L (HRP) preadsorbed (ab97040) secondary antibody
All lanes:
Western blot - Anti-HIF-1 alpha antibody [H1alpha67] (<a href='/en-us/products/primary-antibodies/hif-1-alpha-antibody-h1alpha67-ab1'>ab1</a>) at 5 µg/mL
Lane 1:
Western blot - HeLa nuclear extract lysate (<a href='/en-us/products/cell-lysates/hela-nuclear-extract-lysate-ab150036'>ab150036</a>) at 40 µg
Lane 2:
Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880) at 40 µg
Lane 3:
HeLa nuclear control at 40 µg
Lane 4:
HeLa nuclear DFO treated at 40 µg
Lane 5:
Western blot - Recombinant Human HIF-1 alpha protein (<a href='/en-us/products/proteins-peptides/recombinant-human-hif-1-alpha-protein-ab154478'>ab154478</a>) at 0.001 µg
Secondary
All lanes:
Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/10000 dilution
Predicted band size: 92 kDa
false
Exposure time: 20min
- WB
Unknown
Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (AB180880)
false
- WB
Unknown
Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (AB180880)
false
Product details
We recommend aliquoting the extracts into single use fractions and then storing them at -80°C.
The cells were treated for 24 hours with a 0.5mM solution of Deferoxamine (DFO). DFO is used as a hypoxia-mimetic agent to stabilize Hypoxia Inducible Factor 1 (HIF-1). DFO stabilizes HIF-1 through the inhibition of Prolyl Hydroxylases (PHDs) which target HIF-1 through degradation. The mechanism of DFO inhibition is likely through the chelation of Fe2+ bound to the active site of PHD which is required for enzymatic activity.
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 9:4296 PubMed30327466
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com